MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by BLUMER, J. L.
Right arrow Articles by WEBSTER, L. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by BLUMER, J. L.
Right arrow Articles by WEBSTER, L. T., JR.

Molecular Pharmacology, Vol 16, 1019-1030, Copyright © 1979 by the American Society for Pharmacology and Experimental Therapeutics

Aerobic Metabolism of Niridazole by Rat Liver Microsomes

JEFFREY L. BLUMER 1, RAYMOND F. NOVAK 1, SAMUEL V. LUCAS 1, JANNEY M. SIMPSON 1, and LESLIE T. WEBSTER JR. 1

1 Department of Pharmacology, Northwestern University Medical School, Chicago, Illinois 60611 and the Department of Pharmacology, Case Western Reserve University School of Medicine, Cleveland, Ohio 44106

The metabolism of the anthelmintic nitroheterocyclic compound niridazole by rat liver was studied under aerobic conditions in vitro. Metabolism was localized to the microsomal fraction. Four metabolites of niridazole were isolated from these microsomal systems by high pressure liquid chromatography. The metabolites were characterized by mass spectrometry and 1H Fourier transform nuclear magnetic resonance spectroscopy as the 4-hydroxy, 5-hydroxy, 4,5-dihydroxy and the 4,5-dehydro derivatives of the imidazolidinone ring; the nitrothiazole portion of niridazole apparently was unaltered. The aerobic metabolism was shown to require O2 and exogenous reducing equivalents (NADPH was more effective than NADH), and to be inhibited by CO, suggesting a cytochrome P-450 catalyzed reaction. Inducers of microsomal cytochrome P-450, phenobarbital and 3-methylcholanthrene, were found to enhance niridazole metabolism. Metabolite profiles varied quantitatively with different inducers. Experiments with individual aerobic metabolites showed precursor-product relationships that are consistent with formation of an epoxide intermediate in the overall metabolic sequence.

Submitted on February 26, 1979
Accepted on July 10, 1979







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1979 by the American Society for Pharmacology and Experimental Therapeutics